Stockreport

Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF New SMA STAT genetic test reduces time to provide results from 21 to four days to aid in clinical careEarly treatment of SMA has been shown to slow disease progression a [Read more]